Description:
CDC scientists have developed a rapid, sensitive, and specific real-time PCR assay that is capable of detecting the presence of
Mycobacterium tuberculosis and determining its resistance profile to antibiotics, such as rifampicin and isoniazid. Currently, there are few assays available that are capable of both detecting
M. tuberculosis and determining the bacteria's drug resistance. This assay incorporates multiple fluorescent chemistries, providing a simple and cost-effective method of determining the bacteria's drug resistance. Additionally, this assay may be used to quickly discriminate
Mycobacterium tuberculosis complex (MTBC) strains from non-MTBC strains.